• In re application of the City of New York v Grand Lafayette Properties LLC

    Publication Date: 2005-05-24
    Practice Area:
    Industry:
    Court: Appellate Division, 1st Dept
    Judge:
    Attorneys: For plaintiff:
    for defendant:

    Case Number:

    By Buckley, P.J., Marlow, Sullivan, Gonzalez, Sweeny, JJ. 6085. In re application of the City of New York, relative to acquiring title in fee simple absolute to certain real propert

  • August 15, 2003 | Legal Times

    Advice and Dissent

    They are both Republicans, both committed public servants, and both share responsibility for advising the president on critical matters of law. But White House Counsel Alberto Gonzal

    1 minute read

  • April 27, 2000 | National Law Journal

    Names Behind the News

    NEW PARTNERSBlatt, Hammesfahr & Eaton (Chicago): Joseph G. Lyons.Brown McCarroll & Oaks Hartline L.L.P. (Austin, Texas): Fields Alexander; in its Dallas office, Stephen Drinnon; in Lo

    1 minute read

  • June 14, 2010 | The American Lawyer

    Paul Weiss to Receive $90 Million in Contingency Fees in Alaska Pension Board's $500 Million Negligence Settlement with Mercer

    In February Paul Weiss said that 2009 was the most profitable year in its history. We're pretty sure that record will b

    1 minute read

  • January 9, 2010 | The American Lawyer

    Gay Marriage Civil Rights Trial to Begin in San Francisco Federal Court Monday

    Our previous coverage of the court challenge to California's Proposition 8, the voter-approved state constitutional amendment banning gay marriage, has focused on a href="http://amlawdaily.typepad.co

    1 minute read

  • July 30, 2010 | The American Lawyer

    Bingham Crushes Hopes of Indirect Purchasers Seeking Class Certification in Intel Antitrust Case

    Intel has likely beaten back an enormous consumer antitrust class action brought on behalf of plaintiffs who bought computers with Intel microprocessors. On July 28 these indirect purchasers suffered

    1 minute read

  • August 18, 2003 | Texas Lawyer

    Advice and Dissent

    They are both Republicans, both committed public servants, and both share responsibility for advising the president on critical matters of law. But White House Counsel Alberto Gonzales -- a mo

    1 minute read

  • Clayworth v. Pfizer, Inc.

    Publication Date: 2010-07-12
    Practice Area:
    Industry:
    Date Filed: 2010-07-12
    Court: Ca. Sup. Ct.
    Judge:
    Attorneys: For plaintiff: Attorneys for Appellant: Alioto Law Firm, Joseph M. Alioto, Joseph M. Alioto, Jr., Theresa D. Moore, Angelina Alioto-Grace, Thomas P. Pier; Law Offices of John H. Boone, John H. Boone; Foreman & Brasso, Russell F. Brasso; Law Offices of James M. Dombroski, James M. Dombroski; Law Offices of Jeffery K. Perkins, Jeffrey K. Perkins; Gary D. McCallister & Associates, Gary D. McCallister, Thomas A. Kelliher, Eric I. Unrein and Jaime Goldstein for Plaintiffs and Appellants. Coughlin Stoia Geller Rudman & Robbins, Pamela M. Parker; Schubert Jonckheer Kolbe & Kralowec and Kimberly A. Kralowec for Consumer Attorneys of California as Amicus Curiae on behalf of Plaintiffs and Appellants. Zelle Hofmann Voelbel & Mason, Craig C. Corbitt and Henry A. Cirillo for Pharmacists Planning Services, Inc., as Amicus Curiae on behalf of Plaintiffs and Appellants.
    for defendant: Attorneys for Respondent: Filice Brown Eassa & McLeod, Peter A. Strotz, Paul R. Johnson, William E. Steimle; Davis Polk & Wardwell, Ameila Starr, Arthur F. Golden, William J. Fenrich and Daniel J. Schwartz for Defendant and Respondent AstraZeneca LP. Winston & Strawn, Tyler M. Paetkau, Nicole P. Dogwill, James F. Hurst, Susan A. Pipal, Matthew J. Sullivan; Eimer Stahl Klevorn & Solberg, David M. Stahl, J. Cunyon Gordon and Adam Oyenbanji for Defendant and Respondent Abbott Laboratories. Gibson, Dunn & Crutcher, Jeffrey T. Thomas and James N. Knight for Defendant and Respondent Allergan, Inc. Mayer, Brown, Rowe & Maw, Mayer Brown, Donald M. Falk, John Nadolenco, Mack Anderson; Sheppard Mullin Richter & Hampton, Steven O. Kramer, John P. Stigi III; Hogan & Hartson and Joseph H. Young for Defendant and Respondent Amgen, Inc. Covington & Burling, Elizabeth Abigail Brown, Anita F. Stork, Theodore Voorhees, Jr., and Thomas J. Cosgrove for Defendant and Respondent Boehringer Ingelheim Pharmaceuticals, Inc. Sedgwick, Detert, Moran & Arnold, Paul J. Riehle, Matthew A. Fischer; Cravath, Swaine & Moore, Evan R. Chesler, Elizabeth L. Grayer, Jessica Buturla and Jeffrey B. Korn for Defendant and Respondent Bristol-Myers Squibb Company. Reed Smith, Michael Diane Floyd, Kirsten J. Handelman; Oppenheimer Wolff & Donnelly, Gary Hansen, David Graham and Aaron Mills Scott for Defendant and Respondent Eli Lilly & Company. Irell & Manella, Alexander F. Wiles, John C. Keith; Cleary Gottlieb Steen & Hamilton, George S. Cary, Sara D. Schotland and David I. Gelfand for Defendant and Respondent GlaxoSmithKline PLC. Drinker Biddle & Reath, H. Christian L?Orange, Paul H. Saint-Antoine, Mary E. Kohart, David J. Antczak and Joanne C. Lewers for Defendant and Respondent Hoffmann-La Roche Inc. Folger Levin & Kahn, Crowell & Moring, Beatrice Bich-Dao Nguyen, Samuel Ray Miller, Tracy E. Reichmuth, Cecilia C. Ogbu, Steven E. Wilson; Patterson Belknap Webb & Tyler, William Cavanaugh, Jr., and Cecilia B. Loving for Defendants and Respondents Janssen Pharmaceutica Inc., Johnson & Johnson Health Care Systems, Inc., Ortho Biotech, Inc., and Ortho-McNeil Pharmaceutical, Inc. Hughes Hubbard & Reed, Rita M. Haeusler, John M. Townsend, Scott H. Christensen, James A. Graffam; Orrick, Herrington & Sutcliffe, Robert P. Reznick and David Goldstein for Defendant and Respondent Merck Sharp & Dohme Corp. formerly known as Merck & Co., Inc. Kaye Scholer, Aton Arbisser, Bryant S. Delgadillo, Saul P. Morgenstern, Karin E. Garvey; Faegre & Benson, James A. O?Neal and Kim J. Walker for Defendant and Respondent Novartis Pharmaceuticals Corporation. Nossaman, Gunther, Knox & Elliott, Nossaman, Scott DeVries, Katrina June Lee; Dickstein Shapiro, Peter J. Kadzik, Bernard Nash, Maria Colsey Heard, Milton Marquis and Andres Colin for Defendant and Respondent Pfizer Inc. Latham & Watkins, Charles H. Samel, Jennifer A. Carmassi, Margaret M. Zwisler, Steven H. Schulman and Belinda S. Lee for Defendant and Respondent Pharmaceutical Research and Manufacturers of America. Arnold & Porter, Ronald C. Redcay, Douglas L. Wald, Mark R. Merley, Daniel R. Waldman, Anne P. Davis and Ryan Z. Watts for Defendant and Respondent Wyeth.

    Case Number: No. S166435

    Cite as 10 C.D.O.S. 87895JAMES CLAYWORTH et al., Plaintiffs and Appellants, v. PFIZER, INC., et al., Def

  • September 1, 2010 | The American Lawyer

    Citing Lack of Materiality, Judge Kaplan Denies Class Certification in Subprime Suit Against Financial Products Company

    Time to break out your subprime securities class action scorecard. Mark a win for the defendants. But instead of disposing of a suit against its subsidiary on a motion to dismiss, the financial servic

    1 minute read

  • Lerner v. Forster

    Publication Date: 2003-02-10
    Practice Area:
    Industry:
    Court: U.S. District Court, Eastern District of New York
    Judge:
    Attorneys: For plaintiff:
    for defendant:

    Case Number:

    Judge Platt LERNER v. FORSTER — Defendants Ronald Forster and Mark Garbus, d/b/a/ Forster & Garbus (“F&G”), and First Select, Inc. (“FSI”) (col